Semler Scientific (NASDAQ:SMLR – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $3.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.20 by $3.21, Zacks reports. The company had revenue of $12.41 million during the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.
Semler Scientific Trading Up 3.0 %
Shares of NASDAQ SMLR opened at $52.22 on Thursday. The company has a market cap of $484.08 million, a price-to-earnings ratio of 10.64 and a beta of 1.17. Semler Scientific has a 12 month low of $20.88 and a 12 month high of $81.56. The stock has a 50-day moving average price of $57.20 and a two-hundred day moving average price of $42.51.
Analyst Upgrades and Downgrades
Separately, Lake Street Capital upped their target price on Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a research note on Friday, January 24th.
About Semler Scientific
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.
Featured Stories
- Five stocks we like better than Semler Scientific
- 3 Stocks to Consider Buying in October
- SoundHound AI Stock at a Crossroads—Is a Bottom in Sight?
- How to Most Effectively Use the MarketBeat Earnings Screener
- Hershey’s Sweet Comeback: Why Investors Are Taking Notice
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Reasons Occidental Petroleum Will Gush Higher in 2025
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.